Source: Annual Congress 2001 - Rhinitis, asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Frausing Hansen, P. Lange, J. Vestbo (Copenhagen, Denmark). Reversibility testing in COPD. Eur Respir J 2001; 16: Suppl. 31, 1420

Member's Comments

No comment yet.

Related content which might interest you: Reversibility testing Source: ERS Skills Course 2016 Year: 2016 Reversibility at pulmonary function tests: can it have implications in patients with COPD? Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Exercise testing in the evaluation of pharmacotherapy in COPD Source: Eur Respir Monogr 2018; 80: 235-250 Year: 2018 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Exercise testing in the evaluation of interventions Source: Annual Congress 2007 - PG12 - Cardiopulmonary exercise testing and interpretation Year: 2007 Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Value of ²GOLD² reversibility test criteria in detecting ²reversible² chronic obstructive pulmonary disease (COPD) patients Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD) Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016 Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Predicting exercise endurance in COPD patients by lung function testing Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Features of COPD in correlation with COPD assessment test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Reversibility of airflow limitation in elderly patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 336s Year: 2007 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015